DEL BELLO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.457
EU - Europa 3.848
AS - Asia 1.230
Continente sconosciuto - Info sul continente non disponibili 43
SA - Sud America 15
AF - Africa 14
OC - Oceania 9
Totale 13.616
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.182
CN - Cina 1.065
IT - Italia 1.049
DE - Germania 732
PL - Polonia 640
UA - Ucraina 352
SE - Svezia 289
CA - Canada 273
GB - Regno Unito 220
FI - Finlandia 193
FR - Francia 153
IE - Irlanda 98
BE - Belgio 38
EU - Europa 38
VN - Vietnam 32
IN - India 31
IR - Iran 20
NL - Olanda 18
RU - Federazione Russa 17
TR - Turchia 15
PK - Pakistan 14
KR - Corea 13
EG - Egitto 11
AU - Australia 9
JP - Giappone 9
RO - Romania 9
HK - Hong Kong 8
GR - Grecia 7
PE - Perù 7
PT - Portogallo 7
MY - Malesia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AT - Austria 5
AE - Emirati Arabi Uniti 3
BR - Brasile 3
CH - Svizzera 3
CL - Cile 3
HU - Ungheria 3
RS - Serbia 3
SG - Singapore 3
BY - Bielorussia 2
DK - Danimarca 2
ID - Indonesia 2
IL - Israele 2
IS - Islanda 2
NG - Nigeria 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
IQ - Iraq 1
KH - Cambogia 1
LT - Lituania 1
MX - Messico 1
NO - Norvegia 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
Totale 13.616
Salva come PNG Salva come JPEG
Città #
Fairfield 925
Jacksonville 863
Woodbridge 819
Chandler 602
Warsaw 522
Ann Arbor 517
Houston 502
Ashburn 501
Wilmington 458
Seattle 362
Cambridge 292
Nanjing 275
Camerino 272
Toronto 219
Dearborn 203
San Mateo 140
Lawrence 129
Princeton 129
Kraków 113
Helsinki 109
Beijing 107
Nanchang 103
Boardman 99
Dublin 98
Columbus 97
Ogden 96
Düsseldorf 83
New York 67
Shenyang 63
London 62
Kunming 57
Lachine 50
Jinan 45
San Diego 44
Tianjin 43
Hebei 39
Bremen 38
Changsha 37
Milan 37
Brussels 36
Centro 36
Jiaxing 36
Philadelphia 31
Dong Ket 29
Los Angeles 27
Redwood City 27
Venezia 25
Zhengzhou 25
Ningbo 23
Hefei 21
Leawood 21
Perugia 21
Shanghai 21
Hangzhou 20
Falls Church 19
Monmouth Junction 19
Guangzhou 18
Orange 17
Nürnberg 16
Taizhou 16
Pesaro 15
Venice 15
Washington 15
Tulsa 14
Verona 13
Changchun 12
Kocaeli 12
Lanzhou 12
Norwalk 12
Rome 12
Buffalo 11
Strasbourg 11
Tappahannock 11
Ardabil 10
Auburn Hills 10
Buti 10
Fuzhou 10
Old Bridge 10
West Jordan 10
Augusta 9
Baotou 9
Ancona 8
Dronten 8
Hounslow 8
Seoul 8
Chongqing 7
Council Bluffs 7
Hanover 7
Horia 7
Indiana 7
Lima 7
Macerata 7
Scafati 7
Ascoli Piceno 6
Berlin 6
Islington 6
Kharkiv 6
Münster 6
Nuremberg 6
Sindelfingen 6
Totale 10.094
Salva come PNG Salva come JPEG
Nome #
An Efficient Lewis Acid Catalyzed Povarov Reaction for the One-Pot Stereocontrolled Synthesis of Polyfunctionalized Tetrahydroquinolines 246
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 242
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 239
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation 235
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 231
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine 229
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 223
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 221
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 216
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 208
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 197
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 196
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 196
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 196
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 185
1,4-Dioxane Nucleus as a Suitable Scaffold for the Characterization of Different Receptor Systems 179
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 177
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 177
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 168
Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms 166
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 165
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 162
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 159
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 155
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 150
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 150
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 150
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 148
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 148
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 144
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 143
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 141
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 141
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 140
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 139
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 138
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 137
Effects of imidazoline I2 receptor ligands on acute nociception in rats 137
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 134
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma 133
null 132
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 131
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 130
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 129
null 129
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 127
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 127
Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility 121
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 121
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 120
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 119
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 119
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 119
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 113
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 112
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 109
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 108
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 105
New insights in Au-NHCs complexes as anticancer agents 105
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 101
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 100
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 100
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 100
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 97
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 95
Adenosine receptors as promising targets for the management of ocular diseases 95
Molecular determinants in the binding of novel 1,4-benzodioxan-related α1D-adrenergic receptor antagonists: a computational study 94
BIOLOGICAL PROFILE AND BIOAVAILABILITY OF IMIDAZOLINE COMPOUNDS AFFECT THEIR MODULATORY ACTIVITY ON MORPHINE TOLERANCE 94
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 93
Trekking through receptor chemistry 90
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 90
Imidazoline nucleus as a biologically versatile scaffold 89
Effects of allyphenyline on chronic alcohol intoxication model 89
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 88
Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel alpha1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and alpha1d computational study 88
Design and synthesis of novel imidazoline derivatives potentially targeting dopamine receptors 87
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 86
Copresence of 1,4-dioxane and quinuclidine nuclei in the design of novel muscarinic antagonists 85
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 85
Hybrid molecules from xanomeline and 77-LH-28-1 as potential novel M1 muscarinic agonists 84
Might the observed alpha2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 82
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 82
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 82
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 82
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 81
Aminopyrimidines as inhibitors of the Wnt signalling pathway 81
NOVEL IMIDAZOLINE MOLECULES INSPIRED BY THE PHARMACOLOGICAL PROFILE OF AGMATINE AS POTENTIAL TOOLS IN MANAGING OPIOID ADDICTION 80
Enantiomers of 6,6-diphenyl-1,4-dioxane derivatives to highlight stereochemical requirements for selective alpha1D-AR and 5- HT1A receptor recognition 79
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 78
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 78
Structural motives of imidazoline molecules favouring the serotonin 5-HT1A receptor activation 77
4WD to Travel Inside the 5-HT1A Receptor World 74
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 74
Alpha2C-adrenoceptor modulators: a patent review 73
Activation of primary amines by copper(I)-based Lewis acid promoters in the solventless synthesis of secondary propargylamines 73
Synergic stimulation of serotonin 5-HT1A receptor and α2-adrenoceptors for neuropathic pain relief: Preclinical effects of 2-substituted imidazoline derivatives 71
Novel α1-adrenoreceptor antagonists related to openphendioxan: biological evaluation and α1d computational study 70
Novel muscarinic antagonists designed on the 1,4-dioxane scaffold 67
Efficient Lewis Acid Systems for the A3 Coupling reaction 64
REMEMBERING MARIA PIGINI AND HER TWO DECADES OF IMIDAZOLINES 63
Totale 12.758
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.845
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019623 0 0 0 0 0 0 0 0 0 0 259 364
2019/20202.973 340 120 307 474 162 340 306 280 171 169 93 211
2020/20212.642 131 242 196 239 172 171 345 112 213 158 430 233
2021/20221.428 122 359 38 58 93 63 46 111 122 165 85 166
2022/20231.867 232 71 89 237 186 214 20 118 360 106 152 82
2023/20241.084 195 94 131 52 68 175 76 57 159 62 15 0
Totale 14.071